This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Walgreens' (WBA) AllianceRx Pharmacy Will Now Distribute XDEMVY
by Zacks Equity Research
Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.
Torrid Holdings (CURV) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Torrid Holdings (CURV) delivered earnings and revenue surprises of 40% and 12.18%, respectively, for the quarter ended October 2023. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) reachead $20.79 at the closing of the latest trading day, reflecting no change compared to its last close.
Walgreens (WBA) Launches Rx Savings Finder Digital Tool
by Zacks Equity Research
Walgreens (WBA) introduces Rx Savings Finder to help patients save on prescription medications.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Walgreens Boots Alliance (WBA) reachead $19.98 at the closing of the latest trading day, reflecting a -0.65% change compared to its last close.
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Walgreens Boots Alliance (WBA) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $21.03, indicating a -0.9% shift from the previous trading day.
Walgreens Boots Alliance (WBA) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) concluded the recent trading session at $20.76, signifying a +1.52% move from its prior day's close.
Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DJD
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DJD
Bear of the Day: Walgreens Boots Alliance (WBA)
by Brian Bolan
Competition heated up and Walgreens got the boot.
Here's What Key Metrics Tell Us About Walgreens (WBA) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended August 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Walgreens Boots (WBA) Q4 Earnings Miss Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots (WBA) Q4 retail revenues are impacted by macroeconomic-driven consumer pressure and lower COVID-19 OTC test kit sales.
CPI Increased More Than Expected
by Zacks Equity Research
CPI Increased More Than Expected
CPI, Jobless Claims Send Pre-Markets Lower
by Mark Vickery
The best news in this entire report comes from core CPI year over year, which arrives in-line with estimates at +4.1%.
Walgreens Boots Alliance (WBA) Lags Q4 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -1.47% and 2.50%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
Markets Mostly Higher on Fed Minutes, Ahead of CPI
by Mark Vickery
Year over year, headline CPI is expected to tick down 10 bps to +3.6% and +4.1% on core, down 20 bps.
Business Optimism Index Falls to Four-Month Low
by Zacks Equity Research
Business Optimism Index Falls to Four-Month Low
Pre-Markets Stay in the Green; Pepsi Beats in Q3
by Mark Vickery
Pre-market indices are slightly positive at this hour -- all but the small-cap Russell 2000.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $21.81, indicating a -1.67% shift from the previous trading day.
Seeking Clues to Walgreens (WBA) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Walgreens (WBA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended August 2023.
Earnings Preview: Walgreens Boots Alliance (WBA) Q4 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear of the Day: Dollar General (DG)
by Andrew Rocco
Dollar General is not living up to its defensive, safe-haven reputation. Despite its low-cost offerings, margins are shrinking while growth is slowing - a poor combination.